high-quality innovative medicines
Making Healthy Possible for India
Innovative medicines and delivery technologies are changing healthcare throughout the world. We think it’s time to bring those innovations to Indian patients. That’s why we’re leveraging our expansive U.S. FDA-approved portfolios, industry-leading quality commitment and unique global partnerships to deliver several first-in-market medicines.
Our growing portfolios in Ophthalmology, Oncology, Diagnostics, and Hospital feature several medicines with technologies and delivery systems now available to India patients and providers for the very first time. This highly differentiated portfolio is driven by our deep commitment to understanding market need and delivering solutions tailored to improve health outcomes across the country.
Explore our therapeutic focus areas below and see how we are making a difference in the lives of patients and families in India.
Quality begins with Amneal
Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families.
Additionally, we are proud to be one of the only pharmaceutical companies in India to send our products for a third-party independent quality validation process, providing additional assurance to patients and healthcare professionals.
